Most women and girls with sickle cell disease (SCD) experience disease-related pain during menstrual periods, but many are unaware…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
A small clinical trial testing Agios Pharmaceuticals’ oral therapy candidate tebapivat against a placebo for easing symptoms in people…
Differences in the stiffness of red blood cells may help to explain variations in the severity of sickle cell…
Testing blood levels of certain clotting proteins may help clinicians identify serious complications of sickle cell disease (SCD) in…
Memantine, an oral medication that’s been used for decades to help treat Alzheimer’s disease, is generally tolerated well by…
Emmaus Life Sciences has entered into an agreement to sell the North American rights to Endari (oral L-glutamine), its…
The gene-editing therapy Casgevy (exagamglogene autotemcel) safely and effectively prevents vaso-occlusive crises (VOCs) in children as young as…
As part of a program to support children with sickle cell disease (SCD) and cancers, supplemental insurance company…
Disc Medicine says it’s planning to launch a clinical trial before the end of the year that will test…
A blood test measuring a protein called placental growth factor (PlGF) may help identify women with sickle cell disease…